Ribomic Inc. (TYO:4591)

Ribomic Income Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	-	2	-	65	80	91
Revenue Growth (YoY)	-	-	-	-18.75%	-12.09%	-24.79%
Gross Profit	-334	2	-	65	80	91
Selling, General & Admin	396	385	352	361	313	304
Research & Development	346	667	764	1,491	1,482	957
Other Operating Expenses	-	-	-	-	34	69
Operating Expenses	742	1,052	1,116	1,852	1,829	1,331
Operating Income	-1,076	-1,050	-1,116	-1,787	-1,749	-1,240
Interest & Investment Income	7	4	1	2	-	-
Currency Exchange Gain (Loss)	2	-	10	20	11	-9
Other Non Operating Income (Expenses)	17	31	122	116	103	63
EBT Excluding Unusual Items	-1,050	-1,015	-983	-1,649	-1,635	-1,186
Asset Writedown	-2	-2	-40	-3	-48	-
Pretax Income	-1,052	-1,017	-1,023	-1,652	-1,683	-1,186
Income Tax Expense	1	1	1	1	1	1
Net Income	-1,053	-1,018	-1,024	-1,653	-1,684	-1,187
Net Income to Common	-1,053	-1,018	-1,024	-1,653	-1,684	-1,187
Shares Outstanding (Basic)	44	40	36	31	28	26
Shares Outstanding (Diluted)	44	40	36	31	28	26
Shares Change (YoY)	19.79%	13.25%	14.73%	10.70%	9.29%	61.26%
EPS (Basic)	-23.78	-25.19	-28.69	-53.14	-59.92	-46.16
EPS (Diluted)	-23.78	-25.19	-28.69	-53.14	-59.92	-46.16
Free Cash Flow	-1,033	-1,028	-954	-1,731	-1,509	-1,150
Free Cash Flow Per Share	-23.33	-25.43	-26.73	-55.64	-53.70	-44.73
Gross Margin	-	100.00%	-	100.00%	100.00%	100.00%
Operating Margin	-	-52500.00%	-	-2749.23%	-2186.25%	-1362.64%
Profit Margin	-	-50900.00%	-	-2543.08%	-2105.00%	-1304.40%
Free Cash Flow Margin	-	-51400.00%	-	-2663.08%	-1886.25%	-1263.74%
EBITDA	-1,079	-1,049	-1,106	-1,787	-1,734	-1,214
D&A For EBITDA	-3.08	0.92	10	0.48	15	26
EBIT	-1,076	-1,050	-1,116	-1,787	-1,749	-1,240

Source: S&P Global Market Intelligence. Standard template. Financial Sources.